Anavex Life Sciences Corp (AVXL)

[allthatglitters]

The FDA just granted Novartis Priority Review for their sickle cell disease drug,crizanlizumab, as a result of data from a phase 2 trial. This shortens the review time from 10 to 6 months. I should mention the drug has additional trials in process; however, my point is, the FDA CAN act expeditiously and w/o phase 3 results. SCD is a a rare disease (comparatively);to be blunt, it sucks and the SOC is miserable. AD is common, it sucks, and the SOC is miserable.